Wednesday, November 25, 2009, 2:30am EST - Canadian Markets open in 7 hours.
To create a watchlist or portfolio of shares, Sign-in or Register

Watson Pharmaceuticals Inc. (WPI)

 On Nov 24: 37.05 USD  Up 1.50 (4.22%)  
MORE ON WPI
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
WATSON PHARMACEUTCLS (NYSE:WPI) Delayed quote dataEdit
After Hours: 37.05 0.00 (0.00%) as of 4:22pm EST on 11/24/09
Last Trade: 37.05 USD
Trade Time: Nov 24
Change: Up 1.50 (4.22%)
Prev Close: 35.55
Open: 36.07
Bid: N/A
Ask: N/A
1y Target Est: 37.50
Day's Range: 35.55 - 37.16
52wk Range: 22.16 - 38.48
Volume: 1,895,567
Avg Vol (3m): 1,043,920
Market Cap: 3.93B
P/E (ttm): 19.10
EPS (ttm): 1.94
Div & Yield: N/A (N/A%)
Watson Pharmaceuticals Inc. (WPI)
1d  5d  3m  6m  1y  2y  5y  max 
Free Annual Reports
 Add WPI to Portfolio   Download Data

HEADLINES
• Israel Stocks: Tel Aviv broadly higher; Israel Chemicals in focus
at MarketWatch (Mon, Nov 23)
• Watson Names Robert A. Stewart Senior Vice President, Global Operations Restructures to Create Global Operations, Global Generics Commercial Function
PRNewswire (Mon, Nov 16)
• WATSON PHARMACEUTICALS INC Financials
EDGAR Online Financials (Fri, Nov 13)
• Cephalon, Barr settle Fentora dispute
AP (Thu, Nov 12)
• UPDATE - Cephalon, Barr settle patent infringement suit
at Reuters (Thu, Nov 12)
• Watson Announces Presentation Time Change at Credit Suisse Healthcare Conference
PRNewswire (Tue, Nov 10)
• Watson Pharmaceuticals: Income Statement Analysis for the September 2009 Quarter
at Seeking Alpha (Sun, Nov 8)
• Cephalon's Upside and Downside
at Seeking Alpha (Sun, Nov 8)
• WATSON PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Fri, Nov 6)
• Watson to Present at Credit Suisse Healthcare Conference
PRNewswire (Fri, Nov 6)
• Specialty Pharma Stock Picks From David Amsellem Of Piper Jaffray
Wall Street Transcript (Fri, Nov 6)
• Indian Pharmaceutical Stock Picks From Citi Investment Research: The Sub Continent Goes Global WIth Drug Manufacturing Partnerships
Wall Street Transcript (Thu, Nov 5)
More Headlines for WPI...
ANALYST
EPS Est (next year) (Dec-09) : 2.57
EPS Est (in 2 years) (Dec-10) : 2.65
Avg Rec (current)*: 2.8
PEG Ratio: 1.14
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Watson Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development, manufacture, marketing, sale, and distribution of generic and brand pharmaceutical products primarily in the United States.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices